Advertisement
New Zealand markets closed
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NZD/USD

    0.5969
    -0.0037 (-0.61%)
     
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • OIL

    82.67
    +1.32 (+1.62%)
     
  • GOLD

    2,228.00
    +15.30 (+0.69%)
     

Jazz Pharmaceuticals’ Vyxeos Approved for EU Commercialization

Jazz Pharmaceuticals’ Vyxeos Approved for EU Commercialization

Today, the European Commission (or EC) approved the marketing authorization of Jazz Pharmaceuticals’ (JAZZ) Vyxeos. This authorization covers the treatment of adult individuals with newly diagnosed treatment-associated acute myeloid leukemia with myelodysplasia-related changes (or AML-MRC).